866-997-4948(US-Canada Toll Free)

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trial Review, Q4, 2010

Published By :

GlobalData

Published Date : Oct 2010

Category :

Therapeutic Area

No. of Pages : 46 Pages


GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, Q4, 2010"" provides data on the Chronic Lymphocytic Leukemia (CLL) clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Chronic Lymphocytic Leukemia (CLL)). 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

Scope

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

1. Table of Contents

1. Table of Contents 2
1.1. List of Tables 4
1.2. List of Figures 6

2. Introduction 7
2.1. Chronic Lymphocytic Leukemia (CLL) 7
2.2. Report Guidance 7

3. Clinical Trials by Region 8
3.1. Clinical Trials by Country 9
3.1.1. Top Countries Contributing to Clinical Trials in Asia-Pacific 11
3.1.2. Top Five Countries Contributing to Clinical Trials in Europe 12
3.1.3. Top Countries Contributing to Clinical Trials in North America 13
3.2. Clinical Trials by BRIC Countries 14

4. Clinical Trials by Phase 15
4.1. In Progress Trials by Phase 16

5. Clinical Trials by Trial Status 17
5.1. Unaccomplished Trials of Chronic Lymphocytic Leukemia (CLL) 18
6. Subjects Recruited Over a Period of Time 19

6.1. Enrollment Trends by Phase for the Last Decade 20

7. Prominent Sponsors 21

7.1. Top 10 Companies Participating in CLL Clinical Trials 22

8. Prominent Drug Comparison 24

9. Clinical Trial Profiles 25

9.1. Clinical Trial Overview of Top Companies 25
9.1.1. Abbott Laboratories 25
9.1.2. Roche Pharma AG 25
9.1.3. F. Hoffmann-La Roche Ltd. 26
9.1.4. BioCryst Pharmaceuticals, Inc. 26
9.1.5. Calistoga Pharmaceuticals, Inc. 27
9.1.6. Sanofi-Aventis 27
9.1.7. GlaxoSmithKline plc 28
9.1.8. Pfizer Inc. 28
9.1.9. Pharmacyclics, Inc. 28
9.1.10. Piedmont Oncology Associates 29
9.1.11. Celgene Corporation 29
9.1.12. St. Jude Childrens Research Hospital, Inc. 30
9.1.13. Schering-Plough Corporation (Inactive) 30
9.2. Clinical Trial Overview of Top Universities / Hospitals / Institutes 31
9.2.1. National Cancer Institute (NCI) 31
9.2.2. The University of Texas M. D. Anderson Cancer Center 33
9.2.3. Masonic Cancer Center 34
9.2.4. Veterans Affairs Medical Center 34
9.2.5. Oregon Health and Science University 35
9.2.6. Arizona Cancer Center 35
9.2.7. Gruppo Italiano Trapianto di Midollo Osseo 36
9.2.8. Medical Research Council's Working Party on Leukemia in Adults and Children 36
9.2.9. Dana-Farber Cancer Institute 37
9.2.10. Washington University School of Medicine 37
9.2.11. Fred Hutchinson Cancer Research Center-Technology Transfer 38
9.2.12. Ohio State University Comprehensive Cancer Center 38
9.2.13. National Heart, Lung, and Blood Institute 39
9.2.14. Dartmouth-Hitchcock Medical Center 39
9.2.15. City of Hope National Medical Center 40
9.2.16. University of Michigan Comprehensive Cancer Center 40
9.2.17. Institut Paoli-Calmettes 40
9.2.18. Baylor College of Medicine 41
9.2.19. Centro de Cancer del Hospital Auxilio Mutuo 41
9.2.20. North Shore Long Island Jewish Health System 42

10. Appendix 43
10.1. Abbreviations 43
10.2. Definitions 43
10.3. Research Methodology 44
10.4. Secondary Research 45
10.5. About GlobalData 45
10.6. Contact Us 45
10.7. Disclaimer 46
10.8. Source 46

List of Table


Table 1: CLL Therapeutics Market, Global, Clinical Trials by Zone (%), 2010*
Table 2: CLL Therapeutics Clinical Trials and in Progress Trials Market, Global, by Top Countries, 2010*
Table 3: CLL Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2010*
Table 4: CLL Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010*
Table 5: CLL Therapeutics Clinical Trials, North America, Top Five Countries (%), 2010*
Table 6: CLL Therapeutics Clinical Trials, BRIC Countries, 2010*
Table 7: CLL Therapeutics Clinical Trials, BRIC Countries (%), 2010*
Table 8: CLL Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010*
Table 9: CLL Therapeutics Market, Global, Clinical Trials by Trial Status, 2010*
Table 10: CLL Therapeutics Market, Global, Terminated Clinical Trials, 2010*
Table 11: CLL Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009
Table 12: CLLTherapeutics Clinical Trials, Global, Enrollment Target Trends by Phase and Year, 2001-2010*
Table 13: CLL Therapeutics Clinical Trials, Global, Key Sponsors, 2010*
Table 14: CLL Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010*
Table 15: CLL Clinical Trials by Prominent Drugs, 1982-2010*
Table 16: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2010*
Table 17: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Roche Pharma AG, 2010*
Table 18: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2010*
Table 19: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2010*
Table 20: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Calistoga Pharmaceuticals, Inc., 2010*
Table 21: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2010*
Table 22: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2010*
Table 23: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2010*
Table 24: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics Inc., 2010*
Table 25: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Piedmont Oncology Associates, 2010*
Table 26: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2010*
Table 27: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2010*
Table 28: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough Corporation , 2010*
Table 29: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2010*
Table 30: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2010*
Table 31: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2010*
Table 32: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Veterans Affairs Medical Center, 2010*
Table 33: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregan Health and Science University, 2010*
Table 34: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Arizona Cancer Center, 2010*
Table 35: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Gruppo Italiano Trapianto di Midollo Osseo, 2010*
Table 36: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council’s Working Party on Leukemia in Adults and Children., 2010*
Table 37: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2010*
Table 38: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2010*
Table 39: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center-Technology Transfer, 2010*
Table 40: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2010*
Table 41: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2010*
Table 42: TCLL Therapeutics Clinical Trials Market, Global, Clinical Trials Dartmouth-Hitchcock Medical Center, 2010*
Table 43: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2010*
Table 44: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2010*
Table 45: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Paoli Calmettes, 2010*
Table 46: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2010*
Table 47: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by Centro de Cancer del Hospital Auxilio Mutuo, 2010*
Table 48: CLL Therapeutics Clinical Trials Market, Global, Clinical Trials by North Shore Long Island Jewish Health System, 2010*

List of Chart


Figure 1: CLL Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 8
Figure 2: CLL Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 9
Figure 3: CLL Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 10
Figure 4: CLL Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2010* 11
Figure 5: CLL Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 12
Figure 6: CLL Therapeutics Clinical Trials, North America, Top Countries (%), 2010* 13
Figure 7: CLL Therapeutics Clinical Trials, BRIC Countries (%), 2010* 15
Figure 8: CLL Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 16
Figure 9: CLL Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 17
Figure 10: CLL Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 19
Figure 11: CLL Therapeutics Clinical Trials, Global, Enrollment Target Trends by Phase and Year, 2001-2010* 20
Figure 12: CLL Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 21
Figure 13: CLL Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 22
Figure 14: CLL Clinical Trials by Prominent Drugs, 1982-2010* 24
Figure 15: GlobalData Methodology 44

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *